NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
05/28/2026
Back to search
Official data from USPTO
NOILE-IMMUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NOILE-IMMUNE
ST13
US500000079258761Class
5, 42
Filing
79258761
Registration
5993205
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/16/2026
Trademark type
Word
Nice classes
5, 42
Filing date
02/18/2019
Registration date
02/25/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
MAIHOS, JESSIE ANDREA
Current location
Historical data usage
Holders and representatives
Holders
NOILE-IMMUNE BIOTECH INC.
NOILE-IMMUNE BIOTECH INC.
Representatives
Daniel M. Gurfinkel Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drugs for use in diagnosistreatment and prevention of cancer and tumor; drugs for use in treatment of cancer and autoimmune disease in the field of oncology; biological preparations for the treatment of cancer; biological tissue cultures for medical purposes; tumor suppressing agents; antitumor drugs; drugs and vaccines for the treatment of cancer; antibodies for medical purposes
Class 42
Pharmaceutical drug development servicestestinginspection and research of drugs and provision of guidanceadvice and information relating thereto; design and development of medical technology; conducting clinical trials for others; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of immunology; provision of information on clinical trials; designing of machinesapparatusinstrumentsincluding their partssystems composed of such machinesapparatus and instruments; computer software designcomputer programmingmaintenance of computer software; design and development of computer hardware and software for use in the field of medicine; testing the functionality of machines and research on machines; research services in the field of proteinsantibodiesmicroorganisms and cells; research and development services in the field of antibodies
Publications
History of USPTO decisions and trademark events.
33 publications found
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
05/28/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/18/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
01/27/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/25/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/17/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/25/2020
FIMP
FINAL DISPOSITION PROCESSED
06/25/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/25/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/27/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2019
PUBO
PUBLISHED FOR OPPOSITION
12/10/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/20/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2019
ALIE
ASSIGNED TO LIE
10/31/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2019
ATRV
ATTORNEY REVIEW COMPLETED
10/10/2019
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
10/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/24/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/24/2019
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/12/2019
RFNT
REFUSAL PROCESSED BY IB
07/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/11/2019
RFRR
REFUSAL PROCESSED BY MPU
06/11/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/28/2019
CNRT
NON-FINAL ACTION WRITTEN
05/27/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/24/2019
DOCK
ASSIGNED TO EXAMINER
05/20/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/20/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/16/2019
Continuous trademark protection
Get notified about every new filing that threatens NOILE-IMMUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.